Telledant LLC – FDA Warning Letter, Aug 31, 2010
The FDA and FTC issued a Warning Letter to Apurve Mehra of Telledant LLC, citing violations observed on their websites (biogetica.com, fixdisease.com, quantumcure.com, fixherpes.com, quantumfix.com) in August 2010.
The FDA determined that 21 specific Biogetica products, including "Deliverance From Herpes Kit," "Epilepsy Essentials-Kit," "Diabetes Brittle Essentials-Kit," "Deliverance From Gonorrhea," "Syphilis Formula 1," and "Deliverance From Chlamydia Kit," are promoted for conditions that classify them as drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)]. The therapeutic claims, including product names and testimonials, establish their intent for use in the cure, mitigation, treatment, or prevention of disease, violating the Act.
These products are considered "new drugs" under section 201(p) of the Act [21 U.S.C. § 321(p)] because they are not generally recognized as safe and effective for their claimed uses and lack prior FDA approval under section 505(a) [21 U.S.C. § 355(a)]. Furthermore, these products
ID · a84c4416-2a53-4cf1-b58d-ca1d96512ca4
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.